MRNS

Marinus Pharmaceuticals, Inc. MRNS

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MRNS ANGN ALLK RENB SER FRLN ANPC IRD LIANY ISO
6M -60.43 % 23.21 % -68.66 % -60.56 % -57.04 % 73.07 % 23.56 % 120.90 % -78.07 % -56.48 %
YTD 3.00 % 14.69 % -73.46 % -81.39 % -52.16 % 1.56 % -1.83 % 61.90 % -66.84 % -50.86 %
1Y -76.29 % -10.71 % -71.63 % -73.70 % -53.35 % 3.02 % -27.27 % 96.15 % -64.03 % -68.27 %
3Y -70.11 % -94.12 % -88.29 % -93.00 % -87.58 % -96.77 % -96.85 % 58.14 % -94.24 % -93.39 %
5Y -58.96 % -94.12 % -99.55 % -95.34 % -95.88 % -97.60 % -98.09 % 58.14 % -99.34 % -93.39 %
10Y -94.72 % -94.12 % -98.95 % -97.59 % -97.48 % -97.60 % -98.09 % 58.14 % -99.34 % -93.39 %
From the beginning -93.13 % -94.12 % -98.95 % -97.59 % -97.48 % -97.60 % -98.09 % 58.14 % -99.34 % -93.39 %

Dividend

LianBio